๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma
NCT05842707Refractory or Relapsed B-cell Non-Hodgkin Lymphoma
Aibin Liang๏ผŒMD๏ผŒPh.D.
Phase 1/2
48
Shanghai
2023-01-18
Active, closed
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT05955391Non-small Cell Lung Cancer
Shenzhen TargetRx Co., Ltd.
Phase 2
164
Guangzhou
2023-01-18
Active, closed
The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection๏ผˆBROAD๏ผ‰
NCT05659641Aortic Dissection, Aneurysm, Dissecting, Aneurysm, Vascular Diseases
Permed Biomedical Engineering Co., Ltd
Not applicable
259
Hefei, Chongqing, Fuzhou, Shijiazhuang, Harbin, Wuhan, Nanjing, Nanchang
2023-01-18
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
NCT05923905Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital
Phase 4
64
Beijing
2023-01-18
Active, closed
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
NCT05642780Solid Tumor
Klus Pharma Inc.
Phase 2
240
Guangzhou, Nanning, Wuhan, Changsha, Changchun, Dalian, Weifang, Xiโ€™an
2023-01-17
Active, closed
A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
NCT05593250Asthma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 2
260
Guangzhou
2023-01-17
Recruiting
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
NCT05541822Advanced Solid Tumors
Abion Inc
Phase 2
178
2023-01-17
Recruiting
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
NCT05872724Cervical Cancer
Suzhou Municipal Hospital
Phase 2
32
Suzhou
2023-01-16
Recruiting
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT05702229Gastric Cancer
AstraZeneca
Phase 2
163
Beijing, Hangzhou, Harbin, Hefei, Kunming, Wuhan, Yinchuan, Zhengzhou
2023-01-16
By invitation
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
NCT05635591EBV-associated Haematologic Neoplasms
Tongji Hospital
Phase 1
9
Wuhan
2023-01-16
Recruiting
Testicular Function and Semen Quality in Male Childhood and Adolescent Cancer Survivors
NCT06587477Cancer, Treatment-Related, Late Effect, Semen Analysis
The University of Hong Kong
Observational
200
Hong Kong
2023-01-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
Abivax S.A.
Phase 3
1,116
Wuhu, Beijing, Fuzhou, Guangzhou, Luoyang, Zhengzhou, Wuhan, Shenyang
2023-01-16
Recruiting
Study of SGN1 in Patients With Advanced Solid Tumor
NCT05038150Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd
Phase 1/2
70
Guangzhou, Harbin, Shanghai, Chengdu
2023-01-16
Not yet open
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
NCT05681403Lymphoma, Autologous Hematopoietic Stem Cell Transplantation
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
53
Xi'an
2023-01-15
Recruiting
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
NCT05401071Tuberculosis, Pulmonary
Huashan Hospital
Phase 2/3
2,442
Guiyang, Kaili, Liupanshui, Zunyi, Shanghai, Zhuji
2023-01-13
Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
NCT05614739Urinary Bladder Neoplasms, Neoplasm Metastasis, Ureteral Neoplasms
Eli Lilly and Company
Phase 1
677
Beijing, Guangdong, Hangzhou, Shanghai, Tianjin, Xi'an, Zhejiang
2023-01-12
Recruiting
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
NCT05640791Resectable Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
40
Tianjin
2023-01-12
Recruiting
TR64 in Patients With Advanced Solid Tumors
NCT05649345Advanced Solid Tumor
Tarapeutics Science Inc.
Phase 1
19
Bengbu, Shenyang
2023-01-12
Active, closed
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
NCT05617677Systemic Lupus Erythematosus
Bristol-Myers Squibb
Phase 3
516
Bengbu, Beijing, Xiamen, Guangzhou, Shenzhen, Baoding, Luoyang, Zhengzhou
2023-01-12
Recruiting
A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.
NCT06927349Advanced Solid Tumours
Shandong Boan Biotechnology Co., Ltd
Phase 1
70
Harbin
2023-01-11
Active, closed
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
NCT05555732Metastatic Non Small Cell Lung Cancer
Daiichi Sankyo
Phase 3
1,170
Beijing, Beijing Sheng, Cangzhou, Changchun, Changsha, Chengdu, Chongqing, Fuzhou
2023-01-11
Recruiting
A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors
NCT05615974Malignant Tumors
LaNova Medicines Limited
Phase 1/2
139
Guangzhou, Wuhan, Linyi, Beijing, Shanghai
2023-01-11
Active, closed
Compont - Varicose Veins of the Lower Extremities
NCT06387264Varicose Veins of Lower Limb
Peking University People's Hospital
Not applicable
188
Beijing
2023-01-11
Active, closed
Leber Congenital Amaurosis Inherited Blindness of Gene Therapy Trial(LIGHT)
NCT06088992Leber Congenital Amaurosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
9
Shanghai
2023-01-10
Recruiting
A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction
NCT05692674Breast Cancer
Shanghai Proton and Heavy Ion Center
Phase 2
67
Shanghai
2023-01-10
Active, closed
To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects
NCT07030504Pharmacokinetics
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
72
Shenzhen
2023-01-10
Active, closed
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
NCT05552976Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb
Phase 3
606
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing
2023-01-10
Recruiting
Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer
NCT06173986Esophageal Squamous Cell Carcinoma, Unresectable Locally Advanced Esophageal Cancer
Shanghai Chest Hospital
Phase 1/2
50
Shanghai
2023-01-10
Recruiting
Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer
NCT05676190Colorectal Cancer
ShiCang Yu
Not applicable
80
Chongqing
2023-01-09
Recruiting
Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
NCT06230471Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital
Phase 2
60
Beijing
2023-01-09
Active, closed
A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.
NCT05661955Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma, Non-mucosal Melanoma
BeiGene
Phase 1/2
113
Beijing, Fuzhou, Lanzhou, Guangzhou, Nanning, Zhengzhou, Wuhan, Changsha
2023-01-09
Active, closed
A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
NCT05662241IgG4 Related Disease
Zenas BioPharma (USA), LLC
Phase 3
194
Beijing, Shijiazhuang, Wuhai, Yantai, Shanghai, Taiyuan, Chengdu
2023-01-09
Active, closed
Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers
NCT05621655Rotavirus Infections, Rotavirus Gastroenteritis
MAXVAX Biotechnology Limited Liability Company
Phase 2
1,512
Shangqiu
2023-01-08
Recruiting
Registry Study for Optimal Management of Liver Failure in the Chinese Population
NCT05740696Liver Failure
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an, Ankang, Changsha, Hanzhong, Jinan, Lanzhou, Weinan, Xianyang
2023-01-06
Active, closed
Adult Spinal Muscular Atrophy (SMA) China Registry
NCT05618379Muscular Atrophy, Spinal
Biogen
Observational
200
Beijing, Fuzhou, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Nanchang
2023-01-06
Recruiting
Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fog
NCT07154199COVID-19, Brain Fog, Long COVID, Transcranial Ultrasound Stimulation
Xuanwu Hospital, Beijing
Not applicable
40
Beijing, Jining
2023-01-06
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
NCT05378347Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder), Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Medtronic Cardiovascular
Not applicable
600
2023-01-05
Recruiting
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
NCT05489289Hepatocellular Carcinoma
Akeso
Phase 3
570
Shanghai
2023-01-05
Recruiting
A Study of YUTIQยฎ 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis
NCT05592717Uveitis, YUTIQ
Tianjin Medical University
Observational
15
Tianjin
2023-01-05
Recruiting
Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
NCT05631964Locally Advanced or Metastatic Digestive Tract Tumors, Other Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
26
Shanghai
2023-01-05
Recruiting
99mTc-P137 SPECT/CT in Prostate Cancer
NCT05672485Prostate Cancer
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
40
Xi'an
2023-01-05
Recruiting
Optimized Acupuncture Treatment for Female Stress Urinary Incontinence
NCT05635669Stress Urinary Incontinence
Yin Ping
Not applicable
360
Shanghai
2023-01-04
Recruiting
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
NCT05717699Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event
Capital Medical University
Phase 1
18
Beijing
2023-01-04
Recruiting
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
NCT05717712Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event
Capital Medical University
Phase 1
18
Beijing
2023-01-04
Recruiting
3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer
NCT06161207Gastric Cancer, Surgery
Fujian Medical University
Phase 3
702
Fuzhou
2023-01-03
Active, closed
TCM Daoyin Therapy in Individuals At-risk for COPD
NCT05940480Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Shanghai University of Traditional Chinese Medicine
Not applicable
60
Shanghai
2023-01-03
Recruiting
A Prospective, Multicenter, Randomized, No-treatment Controlled, Assessor-blinded, Superiority Clinical Trial to Evaluate the Efficacy and Safety of Polycaprolactone Gel for Injection to Improve Temple Hollowing in Chinese Adults
NCT06972940Temple Hollowing
AQTIS Medical B.V.
Not applicable
159
Beijing
2023-01-03
Recruiting
Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer
NCT07070011Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Chest Hospital of Shanghai Jiao Tong University
Observational
38
Shanghai
2023-01-03
Recruiting
Clinical Study of OR for Second-line Treatment of Refractory MZL
NCT06134284OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma
Lixia Sheng
Phase 4
39
Hangzhou, Ningbo
2023-01-02
Recruiting
Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
NCT05951517Henoch-Schรถnlein Purpura, Gastrointestinal Injury, Mycophenolate Mofetil
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
24
Guangzhou
2023-01-01
By invitation
Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study
NCT06028412NSCLC, Stage I
Xiaolong Yan, Dr.
Not applicable
660
Xi'an
2023-01-01
Recruiting
Prospective Cohort Study on Refractory Rheumatoid Arthritis
NCT07126431Rheumatoid Arthritis
Peking University Third Hospital
Observational
200
Beijing
2023-01-01
Recruiting
Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
NCT06454396Hemodialysis Access Failure
RenJi Hospital
Observational
480
Shanghai
2023-01-01
By invitation
AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT05678933Peripheral T-cell Lymphoma Targeted Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase 3
200
Tianjin
2023-01-01
Recruiting
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
NCT05800223Non-small Cell Lung Cancer Metastatic
Shanghai Cancer Hospital, China
Phase 3
300
Shanghai
2023-01-01
Active, closed
Key Technology Research and Application Demonstration of Individual Protective Equipment for High-Level Biosafety Laboratories
NCT06697379Biosafety Protection, Infectious Diseases
Minghui Li
Observational
100
Beijing
2023-01-01
By invitation
Prolonged Extubation in Gastric Cancer With OSA
NCT07362706Obstructive Sleep Apnea, Gastric Cancer (GC)
Qilu Hospital of Shandong University
Observational
240
Jinan
2023-01-01
Recruiting
Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
NCT06653517Ameloblastoma, BRAF V600E Mutation Positive
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
12
Shanghai
2023-01-01
Recruiting
Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge
NCT07453342Immune-Related Adverse Events
Peking Union Medical College Hospital
Observational
500
Beijing
2023-01-01
Active, closed
Multimodal CT-Based Risk Stratification for Postoperative Local Recurrence in NSCLC: A Multicenter Study
NCT07552532Lung Cancer (NSCLC)
Guangming Lu
Observational
2,000
Nanjing
2023-01-01
Recruiting
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
NCT07156058Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
204
Beijing
2023-01-01
Recruiting
Integrin ฮฑvฮฒ6-targeted PET in Malignant Tumors
NCT05835570Malignant Neoplasm, PET/CT, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic
Zhongnan Hospital
Observational
200
Wuhan
2023-01-01
Recruiting
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
NCT05978193Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital
Phase 2
100
Shanghai
2023-01-01
Recruiting
The Roles of Exosomal Circ-LRBA and 451/CRTC2 Signaling Axis in Colorectal Cancer
NCT05579353Colorectal Cancer
Jingbo Chen
Observational
200
Jinan
2023-01-01
Active, closed
Pacing Characteristics of a Conventional Bipolar
NCT06011252Symptomatic Bradycardia
Chang Gung Memorial Hospital
Not applicable
134
2023-01-01
Recruiting
Image Driven Hepatocellular Carcinoma Invasiveness Evaluation Research
NCT06559761Hepatocellular Carcinoma Stage III
Chinese PLA General Hospital
Observational
500
Beijing
2023-01-01
Recruiting
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NCT04960839Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
323
Jiangxi, Shanghai, Hangzhou
2023-01-01
Recruiting
The Impact of Preoperative Quantitative Flow Reserve (QFR) on Early Postoperative Radial Artery Graft Outcomes in Coronary Artery Bypass Grafting
NCT07669987Quantitative Flow Reserve, Minimally Invasive Coronary Surgery, Radial Artery
Peking University Third Hospital
Observational
110
Beijing
2023-01-01
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
NCT05535413Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine, UDT1
Hunan Cancer Hospital
Phase 1/2
30
Changsha
2023-01-01
Recruiting
PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy
NCT05980715HNSCC, Radiotherapy, PD-1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
324
Guangzhou
2023-01-01
Recruiting
Clinical Study on the Treatment of Pelvic Pain With Wearable Dual-band LED Device
NCT06982989Pelvic Pain
Peking University Third Hospital
Not applicable
250
Beijing
2023-01-01
Recruiting
Feedback Loop Between Intracranial Atherosclerosis and Cerebral Small Vessel Disease
NCT05677607ICAS - Intracranial Atherosclerosis, Cerebral Small Vessel Diseases
Chinese PLA General Hospital
Observational
300
Beijing
2023-01-01
Recruiting
Prospective Cohort Study of the Risk of Recurrent Atrial Fibrillation After Radiofrequency Ablation
NCT05638841Atrial Fibrillation
Peking University Third Hospital
Observational
300
Beijing
2023-01-01
Recruiting
Researching the Useful of Barb Suture in Obese Patients Undergoing Posterior Cervical Surgery
NCT05895968Cervical Spinal Stenosis, Posterior Cervical Spine Surgery, Barbed Suture
Xijing Hospital
Not applicable
60
Xi'an
2023-01-01
Recruiting
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
NCT05830812Lung Adenocarcinoma, Stage I
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
3,000
Wuhan
2023-01-01
Recruiting
Single Port Endoscopic Breast Conserving Surgery
NCT06593132Breast Conserving Surgery, Endoscopic Surgery
Ren,Yu
Observational
200
Xi'an
2023-01-01
Recruiting
Idiopathic Generalized Epilepsy Syndromes
NCT06388174Epilepsy, Epilepsy, Idiopathic Generalized
Shen Chun-Hong
Observational
200
Hangzhou
2023-01-01
Recruiting
Observation on the Correlation Between Serum/Fecal Isoflavones, Abundance of TMA-producing Bacteria and Serum TMAO in Hyperlipidemia and Healthy Subjects
NCT06890780Hyperlipidemia
Zhujiang Hospital
Observational
200
Guangzhou
2023-01-01
Recruiting
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
NCT04777175Non Small Cell Lung Cancer
Yongchang Zhang
Observational
186
Changsha
2023-01-01
Recruiting
The Clinical Study of 3D-printed Magnesium Alloy Prosthesis With Controllable Degradation Rate in the Repair of Periarticular Bone Defects
NCT06349629Degradation of Magnesium Alloy Prosthesis and New Bone Regeneration
Peking University Third Hospital
Not applicable
60
Beijing
2023-01-01
By invitation
The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens
NCT07035535Antimicrobial Drug Resistance, High-Throughput Nucleotide Sequencing
The First Affiliated Hospital with Nanjing Medical University
Observational
200
Nanjing
2023-01-01
Recruiting
Retzius-sparing Robot-assisted Radical Prostatectomy With "Sandwich" Technique of Total Urethral Reconstruction Versus Standard Robot-Assisted Radical Prostatectomy Versus Laparoscopic Radical Prostatectomy Surgery: A Comparative Prospective Study of 300 Patients
NCT06730243Retzius-sparing Robot-assisted Radical Prostatectomy With "Sandwich" Technique of Total Urethral Reconstruction
Ministry of Science and Technology of the Peopleยดs Republic of China
Not applicable
300
Beijing
2023-01-01
Recruiting
MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment
NCT05957679Spinal Cord Tumors
Shengjing Hospital
Not applicable
20
Shenyang
2023-01-01
Recruiting
Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar Defects
NCT07610668Infertility
Tang-Du Hospital
Observational
300
Xi'an
2023-01-01
Recruiting
Risk Assessment and Mechanism Analysis of Intracranial Multiple Aneurysm Instability Based on High-resolution Magnetic Resonance, Imaging Histology and Hemodynamics
NCT06539767Arterial Aneurysm Wall Enhancement on HRMRI
Zhujiang Hospital
Observational
1,000
Guangzhou
2023-01-01
Recruiting
The Clinical Course and Factors for the Progression of Uninvestigated Dyspepsia to Functional Dyspepsia
NCT05823636Dyspepsia
Air Force Military Medical University, China
Observational
220
Xi'an
2023-01-01
Recruiting
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
NCT07442045Ulcerative Colitis (UC)
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
150
Foshan, Guangzhou, Shenzhen
2023-01-01
By invitation
Does Medial Raw Anchor Necessary During Tendon Repair Combined With Microfracture
NCT06431191Full Rotator Cuff Tear, Microfracture Procedure, Double Raw Repair, Lateral Raw Repair
Beijing Jishuitan Hospital
Not applicable
50
Beijing
2023-01-01
Recruiting
Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China
NCT05735444Hypertension, Obstructive Sleep Apnea
Shanghai Jiao Tong University School of Medicine
Observational
633
Shanghai
2023-01-01
Recruiting
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
NCT07073755Metastatic Breast Cancer, Drug Resistance, Hormone Receptor-Positive Breast Cancer, HER2-positive Breast Cancer
Hunan Cancer Hospital
Observational
200
Changsha
2023-01-01
Recruiting
The Cohort Study for Asthma in China
NCT05937334Asthma, Bronchial
Beijing Chao Yang Hospital
Observational
400
Beijing
2023-01-01
Recruiting
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
NCT05686447Monoclonal Gammopathies, Multiple Myeloma, M-protein
Zhujiang Hospital
Observational
200
Guangzhou
2023-01-01
Active, closed
Impact of Pre- and Post-operative Serum Metabolome Dynamics in Colorectal Resection Outcomes
NCT07035262Colo-rectal Cancer
Dong Peng
Observational
400
Chongqing
2023-01-01
Recruiting
Pharmacometrics Analysis of Rivaroxaban in Chinese Children Aged Over 2 Years
NCT06993636Kawasaki Disease, Coronary Artery Aneurysm, Rivaroxaban, Anticoagulant Drugs
Children's Hospital of Fudan University
Observational
60
Shanghai
2023-01-01
By invitation
Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids
NCT06786780Cervical Cancer Treated with Pelvic Radiotherapy, Cervical Cancers
Chongqing University Cancer Hospital
Phase 2
50
Chongqing
2023-01-01
Active, closed
Mechanistic Study of SPARC-Mediated Regulation of Neutrophil Extracellular Trap Formation in the Brain Metastatic Microenvironment of Breast Cancer
NCT07185646Neuro-Oncology, MRI Imaging, Tumor Immune Microenvironment
Second Xiangya Hospital of Central South University
Observational
200
Changsha
2023-01-01
Recruiting
Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
NCT07490236Trilaciclib, CDK4/6-dependent Solid Tumors
Hebei Medical University Fourth Hospital
Phase 1
100
Shijiazhuang
2023-01-01
Recruiting
Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer
NCT05975749Gastric Cancer
Fudan University
Phase 2
114
Shanghai
2023-01-01
Recruiting
The Mechanisms of Underlying Accelerated Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression
NCT05607654Treatment-resistant Depression
First Affiliated Hospital of Zhejiang University
Not applicable
60
Hangzhou
2023-01-01
Active, closed
Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study
NCT05639010End Stage Renal Disease
Changhai Hospital
Not applicable
410
Shanghai
2023-01-01
Rows per page Showing 15801–15900 of 19052
Previous 157 158 159 160 161 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=159

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.